- The assisted reproductive technology market contributed over USD 21 billion in 2014. Increasing infertility cases are the major driving factor of the market. Infertility results primarily from obesity, stress, and lifestyle disorders.
For Market Research Report on “Assisted Reproductive Technology Market” Visit -http://www.grandviewresearch.com/industry-analysis/assisted-reproductive-technology-market
Rise in infertility rates has led people to choose human reproductive technologies. These technologies include intracytoplasmin sperm injections (ICSIs), intrauterine insemination, surrogacy (IUI), in vitro fertilization (IVF), and zygote intrafallopian transfer (ZIFT).
The World Health Organization stated that fertility rate per female has shortened from 5 in 1960 to 2.5 in 2012. This has increased the demand for assistive reproductive technology (ART) procedures. Mounting work pressure, stress, and mental problems also propel demand for the assisted reproductive technology market.
In countries like Canada and U.S., out of ten people, more than six undergo stress at work place. ART procedures involve fresh donor, frozen non- donor, fresh non-donor, and frozen donor. The frozen non-donor segment is estimated to grow at a CAGR over 5% in the upcoming years. On the other hand, with regards to revenue, fresh non-donor segment contributed over USD 11 billion in 2014.
Also, in-vitro fertilization is a broadly used technique. In order to increase success rates, this procedure is carried out by using fresh sperms/eggs. Later on, a new technique, known as Inytacytoplasmic Sperm Injection was also introduced for battling male infertility. This technique ensures that a potent sperm enters the egg and results in pregnancy.
In 2014, North America led the global assisted reproductive technology market. It contributed revenues over USD 8 billion. Constructive governmental support, rising awareness about infertility, and high infertility rates are the key factors driving this region. Asia Pacific is expected to witness significant growth over the forecast period.
The major factors driving the region are late family planning, women employment levels, and increasing disposable incomes. The key growth aspect in the assisted reproductive technology market in India and South Asian countries is the booming medical tourism industries.
The dominating market participants include Cryolab Ltd., European Sperm Bank, Microm UK Ltd, Parallabs, and Origio. In 2013, Parallabs launched a monitoring technique, known as Embroscope. This technique boosted pregnancy rates and also improved IVF systems.
Information Source: Grand View Research
To request a sample copy of this report, please complete the form below.
To purchase a copy of this report, please contact at
28 2nd Street, Suite 3036
San Francisco, CA 94105
Toll Free: 1-888-202-9519